newsfilter
← Latest News
PR Newswire·

Theseus Pharmaceuticals Appoints Steven Stein, M.D. to Board of Directors

CAMBRIDGE, Mass., Oct. 19, 2022 /PRNewswire/ -- Theseus Pharmaceuticals, Inc. (NASDAQ:THRX) (Theseus or the Company), a clinical-stage biopharmaceutical company focused on improving the lives of cancer patients through